Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

AFT Pharmaceuticals Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (199)
Prescription medicine registration (44)
Cancellation by sponsor (30)
Cancellation or suspension (9)
Australian public assessment report (AusPar) (4)
Designation or determination (2)
Prescription medicine evaluation (2)

Date

2026 (9)
2025 (33)
2024 (19)
2023 (30)
2022 (35)
2021 (21)
2020 (17)
2019 (20)
2018 (7)
2017 (14)
2016 (14)
2015 (9)
2014 (6)
2013 (10)
2012 (15)
2011 (3)
2010 (5)
2009 (5)
2008 (2)
2007 (2)
2006 (2)
2005 (3)
2004 (1)
2000 (2)
1999 (1)
1997 (1)
1995 (1)
1992 (2)
1991 (1)

Search

Sponsor content

290 result(s) found, displaying 31 to 40

AFT Pharmaceuticals Pty Ltd - Lubricant, eye Cancelled under Section 41GL(d) of the Act

27 June 2025

Cancellation by sponsor

Requested by AFT Pharmaceuticals Pty Ltd
AFT Pharmaceuticals Pty Ltd - Sterile wound irrigation solution Cancelled under Section 41GL(d) of the Act

27 June 2025

Cancellation by sponsor

Requested by AFT Pharmaceuticals Pty Ltd
AFT Pharmaceuticals Pty Ltd - Hylo-Forte - Lubricant, eye Cancelled under Section 41GL(d) of the Act

27 June 2025

Cancellation by sponsor

Requested by AFT Pharmaceuticals Pty Ltd
AFT Pharmaceuticals Pty Ltd - Hylo-Fresh - Lubricant, eye Cancelled under Section 41GL(d) of the Act

27 June 2025

Cancellation by sponsor

Requested by AFT Pharmaceuticals Pty Ltd
Ropivacaine-AFT 0.2% ropivacaine hydrochloride 400 mg/200 mL solution for infusion bag Cancelled under Section 30(1)(c) of the Act

27 June 2025

Cancellation by sponsor

Requested by AFT Pharmaceuticals Pty Ltd
Ropivacaine-AFT 0.2% ropivacaine hydrochloride 200 mg/100 mL solution for infusion bag Cancelled under Section 30(1)(c) of the Act

27 June 2025

Cancellation by sponsor

Requested by AFT Pharmaceuticals Pty Ltd
Ertapenem-AFT ertapenem (as sodium) 1 g powder for injection vial (423210)

4 November 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Ertapenem-AFT ertapenem (as sodium) 1 g powder for injection vial.
ferro-f-tab tablet blister (new formulation) (466368)

30 October 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ferro-f-tab tablet blister (new formulation).
ferro-tab tablet blister (new formulation) (466367)

30 October 2024

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ferro-tab tablet blister (new formulation).
ONDANSETRON-AFT (AFT Pharmaceuticals Pty Ltd)

2 May 2025

Prescription medicine registration

Active ingredients: ondansetron hydrochloride dihydrate.

Pages

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.